Cancer cells are masters of disguise, evading immune destruction through cunning mechanisms. Groundbreaking research reveals a novel tactic: mitochondrial transfer. Cancer cells cripple immune cells by donating their damaged mitochondria, hindering the immune response and fostering tumour growth.
Mark Daly, Director of the Institute for Molecular Medicine Finland (FIMM), HiLIFE at the University of Helsinki, shares his expertise on medical genetic research on a population scale in Finland.
Dr Craig Titmus, Partner and UK and European Patent Attorney at intellectual property firm, Mathys & Squire, turns the spotlight on genomics and public health from a patent attorney’s perspective.
Dr Kim Hammond-Kosack at Rothamsted Research highlights an aspect of plant pathology that concerns the importance of finding new ways to disarm old enemies in wheat diseases.
Felix Dapare Dakora from Tshwane University of Technology, Pretoria, South Africa, provides a fascinating insight into the world of biological nitrogen fixation in legumes, including the opportunities for green agriculture and increased food security in Africa.
The role of vitamin D in pregnancy is an example of work by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, investigating human development.
Ewan Birney, Director of EMBL’s European Bioinformatics Institute (EMBL-EBI), reveals how genomics could improve healthcare and pave the way to precision medicine.
Gábor Balázsi, Ph.D. from the Louis and Beatrice Laufer Center for Physical and Quantitative Biology and the Department of Biomedical Engineering at Stony Brook University in the U.S., shares his perspective on the field of synthetic biology in terms of the past, present and future.
Data linkage and sharing for healthy longevity together present a global challenge, in the view of Prof Makoto Suematsu, Japan Agency for Medical Research and Development and Rihana Diabo at the World Economic Forum.
The UK government announced the launch of a huge genetics project, working with GlaxoSmithKline and AstraZeneca, to understand diseases like dementia and cancer.
